Skip to main content
logo
Panacea Biotec Limited (NSE:PANACEABIO)
India flag India · Delayed Price · Currency is INR
354.90
-7.35 (-2.03%)
Feb 18, 2026, 12:09 PM IST

Panacea Biotec Revenue

Panacea Biotec had revenue of 1.65B INR in the quarter ending December 31, 2025, with 1.04% growth. This brings the company's revenue in the last twelve months to 6.06B, up 7.55% year-over-year. In the fiscal year ending March 31, 2025, Panacea Biotec had annual revenue of 5.59B, down -0.01%.

Revenue (ttm)
6.06B
Revenue Growth
+7.55%
P/S Ratio
3.66
Revenue / Employee
2.82M
Employees
2,149
Market Cap
22.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20255.59B-740.00K-0.01%
Mar 31, 20245.59B992.22M21.57%
Mar 31, 20234.60B-2.01B-30.44%
Mar 31, 20226.61B364.27M5.83%
Mar 31, 20216.25B807.43M14.84%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Biocon168.27B
Dishman Carbogen Amcis27.97B
Anthem Biosciences20.02B
OneSource Specialty Pharma14.19B
Concord Biotech11.59B
Blue Jet Healthcare10.53B
Supriya Lifescience7.35B
Zota Health Care4.73B
Revenue Rankings

Panacea Biotec News

More News